Clinically relevant pharmacology of neuropsychiatric drugs approved over the last three years: Part II. [electronic resource]
Producer: 20061228Description: 312-6 p. digitalISSN:- 1527-4160
- Anti-HIV Agents -- adverse effects
- Antidepressive Agents -- adverse effects
- Antiparkinson Agents -- adverse effects
- Apomorphine -- adverse effects
- Atazanavir Sulfate
- Azabicyclo Compounds
- Carbamates -- therapeutic use
- Central Nervous System Agents -- adverse effects
- Cytochrome P-450 Enzyme System -- metabolism
- Drug Approval -- legislation & jurisprudence
- Drug Interactions
- Duloxetine Hydrochloride
- Furans
- Humans
- Hypnotics and Sedatives -- adverse effects
- Indenes -- adverse effects
- Long QT Syndrome -- chemically induced
- Mental Disorders -- drug therapy
- Oligopeptides -- adverse effects
- Organophosphates -- therapeutic use
- Piperazines -- adverse effects
- Psychopharmacology -- methods
- Pyridines -- adverse effects
- Sulfonamides -- therapeutic use
- Thiophenes -- adverse effects
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.